These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29238043)

  • 21. Antibody-Drug Conjugates: Ushering in a New Era of Cancer Therapy.
    Hurwitz J; Haggstrom LR; Lim E
    Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting LGSN restores sensitivity to chemotherapy in gastric cancer stem cells by triggering pyroptosis.
    Li YT; Tan XY; Ma LX; Li HH; Zhang SH; Zeng CM; Huang LN; Xiong JX; Fu L
    Cell Death Dis; 2023 Aug; 14(8):545. PubMed ID: 37612301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment.
    Lucianò AM; Di Martile M; Pérez-Oliva AB; Di Caprio M; Foddai ML; Buglioni S; Mulero V; Del Bufalo D
    J Exp Clin Cancer Res; 2023 Jul; 42(1):178. PubMed ID: 37488586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative Analysis of Isoform Switching in Cancer.
    Dolgalev G; Poverennaya E
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular Vesicle-Packaged miR-195-5p Sensitizes Melanoma to Targeted Therapy with Kinase Inhibitors.
    Santos NL; Bustos SO; Reis PP; Chammas R; Andrade LNS
    Cells; 2023 May; 12(9):. PubMed ID: 37174717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brevilin A Isolated from
    Lee D; Kwak HJ; Kim BH; Kim DW; Kim HY; Kim SH; Kang KS
    Plants (Basel); 2022 Jun; 11(13):. PubMed ID: 35807611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the anti-apoptotic Bcl-2 family proteins: machine learning virtual screening and biological evaluation of new small molecules.
    Valentini E; D'Aguanno S; Di Martile M; Montesano C; Ferraresi V; Patsilinakos A; Sabatino M; Antonini L; Chiacchiarini M; Valente S; Mai A; Colotti G; Ragno R; Trisciuoglio D; Del Bufalo D
    Theranostics; 2022; 12(5):2427-2444. PubMed ID: 35265218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles and Regulation of BCL-xL in Hematological Malignancies.
    Morales-Martínez M; Vega MI
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased MCL-1 synthesis promotes irradiation-induced nasopharyngeal carcinoma radioresistance via regulation of the ROS/AKT loop.
    Liang YY; Niu FY; Xu AA; Jiang LL; Liu CS; Liang HP; Huang YF; Shao XF; Mo ZW; Yuan YW
    Cell Death Dis; 2022 Feb; 13(2):131. PubMed ID: 35136016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Making Sense of Antisense Oligonucleotide Therapeutics Targeting Bcl-2.
    Gagliardi M; Ashizawa AT
    Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35056993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer.
    Westaby D; Jimenez-Vacas JM; Padilha A; Varkaris A; Balk SP; de Bono JS; Sharp A
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma
    Patras L; Ionescu AE; Munteanu C; Hajdu R; Kosa A; Porfire A; Licarete E; Rauca VF; Sesarman A; Luput L; Bulzu P; Chiroi P; Tranca RA; Meszaros MS; Negrea G; Barbu-Tudoran L; Potara M; Szedlacsek S; Banciu M
    Cancer Biol Ther; 2022 Dec; 23(1):1-16. PubMed ID: 34964693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack.
    Guha A; Waris S; Nabors LB; Filippova N; Gorospe M; Kwan T; King PH
    Adv Drug Deliv Rev; 2022 Feb; 181():114082. PubMed ID: 34923029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment.
    Azwar S; Seow HF; Abdullah M; Faisal Jabar M; Mohtarrudin N
    Biology (Basel); 2021 Aug; 10(9):. PubMed ID: 34571731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic apoptotic effect of miR-183-5p and Polo-Like kinase 1 inhibitor NMS-P937 in breast cancer cells.
    Kudo M; Zalles N; Distefano R; Nigita G; Veneziano D; Gasparini P; Croce CM
    Cell Death Differ; 2022 Feb; 29(2):407-419. PubMed ID: 34561554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of a Novel BCL-X
    Pal P; Thummuri D; Lv D; Liu X; Zhang P; Hu W; Poddar SK; Hua N; Khan S; Yuan Y; Zhang X; Zhou D; Zheng G
    J Med Chem; 2021 Oct; 64(19):14230-14246. PubMed ID: 34533954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The three as: Alternative splicing, alternative polyadenylation and their impact on apoptosis in immune function.
    Blake D; Lynch KW
    Immunol Rev; 2021 Nov; 304(1):30-50. PubMed ID: 34368964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation.
    Dou Z; Zhao D; Chen X; Xu C; Jin X; Zhang X; Wang Y; Xie X; Li Q; Di C; Zhang H
    J Exp Clin Cancer Res; 2021 Jun; 40(1):194. PubMed ID: 34118966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia-dependent drivers of melanoma progression.
    D'Aguanno S; Mallone F; Marenco M; Del Bufalo D; Moramarco A
    J Exp Clin Cancer Res; 2021 May; 40(1):159. PubMed ID: 33964953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcl-xL: A Focus on Melanoma Pathobiology.
    Lucianò AM; Pérez-Oliva AB; Mulero V; Del Bufalo D
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.